Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment.
Nishida
S
S
Hagihara
K
K
Shima
Y
Y
Kawai
M
M
Kuwahara
Y
Y
Arimitsu
J
J
Hirano
T
T
Narazaki
M
M
Ogata
A
A
Yoshizaki
K
K
Kawase
I
I
Kishimoto
T
T
Tanaka
T
T
D000686:Amyloidosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003108:Colonic Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007077:Ileal Diseases / Q000188:drug therapy*; D008875:Middle Aged; D019947:Receptors, Interleukin-6
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D019947:Receptors, Interleukin-6; C502936:tocilizumab